Immunoglobulin G immune response to SARS-CoV-2 vaccination in people living with multiple sclerosis within Multiple Sclerosis Partners Advancing Technology and Health Solutions. (June 2022)
- Record Type:
- Journal Article
- Title:
- Immunoglobulin G immune response to SARS-CoV-2 vaccination in people living with multiple sclerosis within Multiple Sclerosis Partners Advancing Technology and Health Solutions. (June 2022)
- Main Title:
- Immunoglobulin G immune response to SARS-CoV-2 vaccination in people living with multiple sclerosis within Multiple Sclerosis Partners Advancing Technology and Health Solutions
- Authors:
- Cohen, Jeffrey A
Bermel, Robert A
Grossman, Cynthia I
Hersh, Carrie M
Hyland, Megan
Mowry, Ellen M
Naismith, Robert
Naylor, Maria L
Nicholas, Jacqueline
Rajbhandar, Rajani
Singh, Carol M
Tintorè, Mar
Zabalza, Ana
Ziemssen, Tjalf
Williams, James R
Montalban, Xavier - Abstract:
- Background: The impact of multiple sclerosis (MS) disease-modifying therapies (DMTs) on SARS-CoV-2 vaccination response is uncertain. Methods: Post-SARS-CoV-2 vaccination blood samples across multiple DMTs were tested for SARS-CoV-2 immunoglobulin G (IgG) response. Results: Three hundred twenty-two people with MS were included; 91.9% received an mRNA vaccine. Post-vaccination reactive IgG rates (IgG index > 1) were 40% for anti-CD20 (32/80 patients); 41% for sphingosine 1-phosphate receptor modulators (S1PRM, 16/39); and 100% for all other classes, including the no DMT group. Conclusion: Anti-CD20 therapies and S1PRMs reduce IgG response to SARS-CoV-2 vaccination; IgG response is preserved with other DMTs.
- Is Part Of:
- Multiple sclerosis. Volume 28:Number 7(2022)
- Journal:
- Multiple sclerosis
- Issue:
- Volume 28:Number 7(2022)
- Issue Display:
- Volume 28, Issue 7 (2022)
- Year:
- 2022
- Volume:
- 28
- Issue:
- 7
- Issue Sort Value:
- 2022-0028-0007-0000
- Page Start:
- 1131
- Page End:
- 1137
- Publication Date:
- 2022-06
- Subjects:
- Multiple sclerosis -- disease-modifying therapy -- SARS-COV-2 vaccination -- humoral immune response -- MS PATHS -- optimal management
Central nervous system -- Diseases -- Periodicals
Myelin sheath -- Diseases -- Periodicals
Inflammation -- Periodicals
Multiple sclerosis -- Periodicals
Central Nervous System Diseases -- Periodicals
Demyelinating Diseases -- Periodicals
Inflammation -- Periodicals
Multiple Sclerosis -- Periodicals
Système nerveux central -- Maladies -- Périodiques
Gaine de myéline -- Maladies -- Périodiques
Inflammation (Pathologie) -- Périodiques
Sclérose en plaques -- Périodiques
Electronic journals
616.834005 - Journal URLs:
- http://msj.sagepub.com/ ↗
http://search.ebscohost.com/login.aspx?direct=true&db=a2h&jid=DZL&site=ehost-live ↗
http://www.uk.sagepub.com/home.nav ↗
http://firstsearch.oclc.org ↗
http://firstsearch.oclc.org/journal=1352-4585;screen=info;ECOIP ↗
http://www.arnoldpublishers.com/journals/pages/mul_scl/13524585.htm ↗ - DOI:
- 10.1177/13524585211061343 ↗
- Languages:
- English
- ISSNs:
- 1352-4585
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 20710.xml